精华制药(002349) - 2014 Q1 - 季度财报(更新)

Financial Performance - Operating revenue for Q1 2014 was CNY 159,197,793.95, a decrease of 12.35% compared to the same period last year[8]. - Net profit attributable to shareholders was CNY 10,377,863.27, down 35.97% year-on-year[8]. - Net profit excluding non-recurring gains and losses was CNY 10,012,514.19, reflecting a decline of 37.9% compared to the previous year[8]. - The basic earnings per share for Q1 2014 was CNY 0.05, down 37.5% from CNY 0.08 in the same period last year[8]. - The company expects net profit attributable to shareholders for the first half of 2014 to range from 1,863 to 2,927 million, reflecting a decrease of 30% to an increase of 10% compared to the same period in 2013[22]. Cash Flow and Assets - Net cash flow from operating activities improved significantly to CNY 8,154,083.48, a 162.68% increase from a negative cash flow in the same period last year[8]. - Total assets at the end of the reporting period were CNY 1,040,752,530.89, a decrease of 2.81% from the end of the previous year[8]. - Net assets attributable to shareholders increased to CNY 680,884,700.51, representing a growth of 1.65% compared to the previous year[8]. - Accounts receivable decreased by 75.43% to 4,402,098.26 from 17,918,315.09 due to increased use of bank acceptance bills during the reporting period[15]. - Cash paid for purchasing goods and services decreased by 38.15% to 80,544,074.14 from 136,512,626.49 due to increased use of bank acceptance bills[15]. Expenses and Liabilities - Development expenses increased by 44.00% to 3,600,000.00 from 2,500,000.00 due to higher R&D investments during the reporting period[15]. - Sales expenses rose by 58.94% to 23,806,646.34 from 14,978,053.71 due to market expansion and adjustments in sales policies[15]. - Financial expenses surged by 485.77% to 2,131,963.21 from -552,652.82 due to increased interest on bank loans[15]. - Asset impairment losses increased by 2893.89% to 2,638,067.31 from -94,422.66 due to higher inventory write-downs at a subsidiary[15]. - Tax payable decreased by 33.42% to 5,702,041.52 from 8,563,588.75 as a result of reduced value-added tax payable[15]. - Income tax expenses decreased by 41.03% to 2,554,154.83 from 4,331,155.51 due to reduced profits during the reporting period[15]. Shareholder Information - The total number of shareholders at the end of the reporting period was 7,572[11]. - The largest shareholder, Nantong Industrial Holdings Group Co., Ltd., held 41.3% of the shares[11]. - Government subsidies recognized in the current period amounted to CNY 799,865.17[9]. Operating Income - Operating income increased by 44.34% to 799,865.17 from 554,158.00 due to increased government subsidies received[15].